KIN
发表于 2025-3-25 07:15:49
http://reply.papertrans.cn/67/6662/666181/666181_21.png
chastise
发表于 2025-3-25 10:55:32
http://reply.papertrans.cn/67/6662/666181/666181_22.png
阉割
发表于 2025-3-25 15:19:13
Stable and Homogeneous Drug Conjugation by Sequential Bis-Alkylation at Disulphide Bonds Using Bis- disulphide bond in antibodies and antibody fragments. We have demonstrated that the bis-sulphone-derived conjugates retain antigen-binding, are stable in serum and exhibit potent and antigen-selective cell killing in both in vitro and in vivo cancer models. Disulphide re-bridging conjugation is a g
agglomerate
发表于 2025-3-25 19:28:49
Calicheamicin Antibody-Drug Conjugates for Liquid and Solid Tumor Indications,evelopment, including the ADC, inotuzumab ozogamicin, targeting CD22-positive, liquid tumors including NHL and ALL, and the CD33-targeting gemtuzumab ozogamicin, targeting AML..The recent expansion of the utility of calicheamicin conjugates to solid tumors may have a broader impact on ADC developmen
含糊
发表于 2025-3-25 23:59:40
Enzyme-Based Strategies to Generate Site-Specifically Conjugated Antibody Drug Conjugates,C brentuximab vedotin (Adcetris.) and the anti-HER-2 ADC trastuzumab-emtansine (Kadcyla.), are approved for cancer therapy. In fact, Kadcyla. is only approved as a second-line therapy in breast cancer due to a limited clinical benefit in comparison to standard therapy as a first-line therapy. There
高兴去去
发表于 2025-3-26 00:19:10
http://reply.papertrans.cn/67/6662/666181/666181_26.png
裂缝
发表于 2025-3-26 05:27:04
http://reply.papertrans.cn/67/6662/666181/666181_27.png
debble
发表于 2025-3-26 11:46:31
http://reply.papertrans.cn/67/6662/666181/666181_28.png
machination
发表于 2025-3-26 16:27:52
http://reply.papertrans.cn/67/6662/666181/666181_29.png
比赛用背带
发表于 2025-3-26 19:45:09
http://reply.papertrans.cn/67/6662/666181/666181_30.png